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ABSTRACT 
Sedentariness and increased body fat are the leading risk factors for developing insulin resistance, obesity, 
and type 2 diabetes. We have shown that muscle contraction induced by electrical pulse stimulation 
increase GLUT4 content in an in vitro primary cell culture model. Neuromuscular electrical stimulation 
(NMES) is a novel alternative strategy to induce muscle contraction in humans. Although widely used in 
rehabilitation settings to prevent muscle atrophy, effectiveness of NMES-induced muscle contractions in 
improving metabolic health is not clear. PURPOSE: To investigate the effects of four weeks of NMES on 
glucose tolerance, substrate utilization, and muscle mass in a sedentary overweight/obese population. 
METHODS: Sedentary overweight/obese participants were randomized into either a control (n=5; age: 
42.2  5.0 years; BMI= 32.8  1.5 kg/m2) or NMES (n=5; age: 30.3  4.5 years; BMI= 32.7  2.3 kg/m2) 
group. All participants received bilateral quadriceps stimulation (12 sessions; 30 minutes/session; 3 
times/week) either using low intensity sensory level (control) or at high intensity neuromuscular level 
(NMES) for four weeks (50Hz; 300s pulse width). Insulin sensitivity was assessed by three-hour oral 
glucose tolerance test (OGTT), substrate utilization was assessed by measuring blood lactate (acute effects) 
and indirect calorimetry (respiratory quotient, RQ) and body composition was measured by dual X-ray 
absorptiometry. RESULTS: Control and NMES groups had comparable fasting blood glucose (Control 
110.2  21.1; NMES 96  3.9 mg/dL; p=0.53), glucose tolerance (Control 430.73  20.23; NMES 455.55  
26.07; AU; p=0.49), substrate utilization measured by RQ (Control 0.78  0.02; NMES 0.78  0.02; p=0.99), 
and muscle mass (Control 48.6  5.5; NMES 47.3  4.3; kg; p=0.86) at baseline. Four weeks of NMES 
resulted in a significant improvement in blood glucose measured after 2 hours of glucose drink 
consumption during OGTT (150.90  7.59 to 138.20  7.61 mg/dL, p=0.03) whereas no change was 
observed in control group (151.75  6.14 to 173.20  34.17 mg/dL, p=0.12). Insulin sensitivity measured by 
glucose area under the curve (AUC), trended to improve with NMES (455.55  26.07 to 415.36  25.89 AU; 
p=0.07), whereas no change was observed in control (430.73  20.23 to 494.68  77.21 AU; p=0.32). Lactate 
accumulation (AUC) assessed during 30 min of NMES was significantly greater compared to that of 
control group (Control 0.87  0.07; NMES 1.22  0.14 AU; p<0.04). CONCLUSION: NMES is a novel and 
effective strategy to improve glucose utilization and insulin sensitivity in an at-risk overweight/obese 
sedentary population in the absence of substrate utilization and muscle mass improvement.  
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